Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 2

Review

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

       
Total article views   HTML views PDF downloads Totals
10,972 Dovepress* 10,972+ 2,518 13,490
Totals 10,972 2,518 13,490
*Since 21 May 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on Google Scholar